Lilly Weighs On Novo After Unveiling A New Finding For Obesity Drugs

stock skidded Monday after a new study showed patients who stopped taking weight-loss drug Zepbound slowly regained weight over a year. The study published in the Journal of the American Medical Association is one of the first to analyze the long-term impact of stopping treatment with a…#jeffemmick #lilly #elililly #novonordisk #nvo #zepbound #marketsmithcom #allisongatlin #ibdagatlin #crisprsurgesafter
Source: Reuters: Health - Category: Consumer Health News Source Type: news